News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Active Biotech AB Presents New Pre-clinical Data for the 57-57 Project at the 8th World Congress on Inflammation
June 18, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LUND, SWEDEN--(MARKET WIRE)--Jun 18, 2007 -- Active Biotech (OMX Nordic: ACTI) has presented pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation (www.inflammation2007.dk) held in Copenhagen June 16-20*.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Europe
MORE ON THIS TOPIC
Psychedelics
Definium’s LSD asset beats analyst expectations in Phase 3 anxiety readout
August 12, 2026
·
4 min read
·
Gabrielle Masson
FDA
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
August 12, 2026
·
1 min read
·
Jef Akst
Manufacturing
Scholar Rock rejigs approval filing after FDA flags violations at Novo plant
August 11, 2026
·
2 min read
·
Nick Paul Taylor
Women’s health
AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashes
August 11, 2026
·
1 min read
·
Tristan Manalac